Portola Pharmaceuticals Inc  

(Public, NASDAQ:PTLA)   Watch this stock  
Find more results forPTLA
30.71
Dec 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 19.59 - 31.48
Open     -
Vol / Avg. 0.00/353,164.00
Mkt cap 1,493.50M
P/E     -
Div/yield     -
EPS -3.01
Shares 48.63M
Beta     -
Inst. own 81%
Feb 25, 2015
Q4 2014 Portola Pharmaceuticals Inc Earnings Release (Estimated) - 4:00pm GMT-5 - Add to calendar
Nov 12, 2014
Portola Pharmaceuticals Inc at Credit Suisse Healthcare Conference
Nov 10, 2014
Q3 2014 Portola Pharmaceuticals Inc Earnings Call - Webcast
Nov 10, 2014
Q3 2014 Portola Pharmaceuticals Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -1474.78% -791.49%
Operating margin -1474.12% -799.34%
EBITD margin - -785.68%
Return on average assets -50.06% -35.34%
Return on average equity -63.65% -159.12%
Employees 70 -
CDP Score - -

Address

270 East Grand Avenue, Suite 22
SOUTH SAN FRANCISCO, CA 94080
United States - Map
+1-650-2446864 (Phone)
+1-650-2467376 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Portola Pharmaceuticals, Inc. (Portola) is a biopharmaceutical company developing product candidates that have the potential to represent advances in the fields of thrombosis and hematology. The Company is advancing its three wholly owned programs using biomarker and genetic approaches.

Officers and directors

Charles J. Homcy M.D. Co-Chairman of the Board
Age: 65
Bio & Compensation  - Reuters
Hollings C. Renton III Independent Co-Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
William Lis Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Mardi C. Dier Chief Financial Officer, Executive Vice President
Age: 49
Bio & Compensation  - Reuters
John T. Curnutte M.D. Ph.D. Executive Vice President - Research & Development
Age: 61
Bio & Compensation  - Reuters
Peter Strumph Vice President - Technical and Clinical Operations
Bio & Compensation  - Reuters
John H. Johnson Director
Age: 56
Bio & Compensation  - Reuters
Jeffrey W. Bird M.D., Ph.D. Independent Director
Age: 54
Bio & Compensation  - Reuters
Robert C. Califf M.D. Independent Director
Age: 63
Bio & Compensation  - Reuters
Nicholas G. Galakatos Ph.D. Independent Director
Age: 56
Bio & Compensation  - Reuters